This inventor holds 1 USPTO granted patent. Top assignee: Retinal Solutions LLC. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Wendelin Dailey: Innovator in Gene Therapy
Introduction
Wendelin Dailey is a notable inventor based in Ann Arbor, MI. He has made significant contributions to the field of gene therapy, particularly in the treatment of diseases. His innovative work has led to the development of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Wendelin Dailey holds a patent titled "Norrin Induced Expression of Genes and Use Thereof to Treat Disease." This patent represents his innovative approach to utilizing gene expression for therapeutic purposes. It highlights his commitment to finding solutions for complex medical challenges. He has 1 patent to his name, reflecting his impactful contributions to the field.
Career Highlights
Dailey is currently associated with Retinal Solutions LLC, where he continues to work on groundbreaking research and development in gene therapy. His role at the company allows him to collaborate with other experts in the field and push the boundaries of what is possible in medical treatment.
Collaborations
Wendelin Dailey collaborates with Kenneth Mitton, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving significant advancements in medical research.
Conclusion
Wendelin Dailey's work in gene therapy and his patent on gene expression demonstrate his commitment to improving healthcare through innovation. His contributions are paving the way for new treatments and solutions in the medical field.